Case Report
BibTex RIS Cite

“Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?

Year 2015, Volume: 2 Issue: 5, 316 - 17, 06.07.2015

Ezgi Yenigun Didem Turgut Erdem Alaguney Ramazan Ozturk Serhan Piskinpasa Fatih Dede

https://doi.org/10.17546/msd.09431

Abstract

We hereby describe a 46-year woman with nephrotic syndrome and new-onset breast cancer. This patient admitted to our hospital with peripheral edema and a mass in her right breast. Membranous glomerulonephritis (MGN) was the etiology of nephrotic syndrome. MGN has been reported in association with a wide variety of solid neoplastic diseases, although rarely occurs as a complication of breast carcinoma. We report a rare and a resistant case of MGN, who was concomitant diagnosed with breast cancer and there was no improvement in proteinuria although breast cancer was under-controlled with cheomotheraphy and surgery. 

Keywords

breast cancer; proteinuria; treatment

References

  • Valcamonico F, Ferrari V, Simoncini E, Gregorini G, Vassalli L, Amoroso V., et al. Paraneoplastic Nephrotic Syndrome in Advanced Breast Cancer Patient. A Case Report. Tumori 2004; 90 (1): 154-156.
  • Eagen JW, Lewis EJ. Glomerulopathies of neoplasia. Kidney Int 1977; 11:297-306.
  • Pai P, Bone JM, McDicken I, Bell GM. Solid tumour and glomerulopathy. Q J Med 1996; 89:361-367.
  • Ozawa T, Pluss R, Lacher J, Boadecker E, Guggenheim S, Hammond W., et al. Endogenous immune complex nephropathy associated with malignancy: studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterisation of tumour specific antigen and antibody and circulating immune complexes. Q J Med 1975; 44:523-541.
  • Gagliano RG, Costanzi JJ, Beathard GA, Sarles HE, Bell JD. The Nephrotic Syndrome Associated with Neoplasia: An Unusual Paraneoplastic Syndrome Report of a Case and Review of the Literature. Am J Med 1976; 60:1026-1031.

Year 2015, Volume: 2 Issue: 5, 316 - 17, 06.07.2015

Ezgi Yenigun Didem Turgut Erdem Alaguney Ramazan Ozturk Serhan Piskinpasa Fatih Dede

https://doi.org/10.17546/msd.09431

Abstract

References

  • Valcamonico F, Ferrari V, Simoncini E, Gregorini G, Vassalli L, Amoroso V., et al. Paraneoplastic Nephrotic Syndrome in Advanced Breast Cancer Patient. A Case Report. Tumori 2004; 90 (1): 154-156.
  • Eagen JW, Lewis EJ. Glomerulopathies of neoplasia. Kidney Int 1977; 11:297-306.
  • Pai P, Bone JM, McDicken I, Bell GM. Solid tumour and glomerulopathy. Q J Med 1996; 89:361-367.
  • Ozawa T, Pluss R, Lacher J, Boadecker E, Guggenheim S, Hammond W., et al. Endogenous immune complex nephropathy associated with malignancy: studies on the nature and immunopathogenic significance of glomerular bound antigen and antibody, isolation and characterisation of tumour specific antigen and antibody and circulating immune complexes. Q J Med 1975; 44:523-541.
  • Gagliano RG, Costanzi JJ, Beathard GA, Sarles HE, Bell JD. The Nephrotic Syndrome Associated with Neoplasia: An Unusual Paraneoplastic Syndrome Report of a Case and Review of the Literature. Am J Med 1976; 60:1026-1031.
There are 5 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Case Reports
Authors

Ezgi Yenigun

Didem Turgut

Erdem Alaguney

Ramazan Ozturk

Serhan Piskinpasa

Fatih Dede This is me

Publication Date July 6, 2015
Published in Issue Year 2015 Volume: 2 Issue: 5

Cite

APA Yenigun, E., Turgut, D., Alaguney, E., Ozturk, R., et al. (2015). “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Medical Science and Discovery, 2(5), 316-17. https://doi.org/10.17546/msd.09431
AMA Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F. “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Med Sci Discov. July 2015;2(5):316-17. doi:10.17546/msd.09431
Chicago Yenigun, Ezgi, Didem Turgut, Erdem Alaguney, Ramazan Ozturk, Serhan Piskinpasa, and Fatih Dede. ““Nephrotic Syndrome Associated With Breast Cancer; When Should It Be Treated?”. Medical Science and Discovery 2, no. 5 (July 2015): 316-17. https://doi.org/10.17546/msd.09431.
EndNote Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F (July 1, 2015) “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Medical Science and Discovery 2 5 316–17.
IEEE E. Yenigun, D. Turgut, E. Alaguney, R. Ozturk, S. Piskinpasa, and F. Dede, ““Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?”, Med Sci Discov, vol. 2, no. 5, pp. 316–17, 2015, doi: 10.17546/msd.09431.
ISNAD Yenigun, Ezgi et al. ““Nephrotic Syndrome Associated With Breast Cancer; When Should It Be Treated?”. Medical Science and Discovery 2/5 (July 2015), 316-17. https://doi.org/10.17546/msd.09431.
JAMA Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F. “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Med Sci Discov. 2015;2:316–17.
MLA Yenigun, Ezgi et al. ““Nephrotic Syndrome Associated With Breast Cancer; When Should It Be Treated?”. Medical Science and Discovery, vol. 2, no. 5, 2015, pp. 316-17, doi:10.17546/msd.09431.
Vancouver Yenigun E, Turgut D, Alaguney E, Ozturk R, Piskinpasa S, Dede F. “Nephrotic Syndrome Associated with Breast Cancer; When should it be treated?. Med Sci Discov. 2015;2(5):316-17.
 Download Cover Image